Drug-eluting stents

Chronic Ischemic cardiopathy

ABSORB III: Everolimus Eluting Bioresorbable Scaffolds for Coronary Artery Disease

Original Title: Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease. Reference: Stone, M.D. for the ABSORB III Investigators. N...

solaci - 20 November, 2015

Drug-eluting stents

OPTIDUAL: Dual Antiaggregation Not Beneficial after 12 Months.

Extending dual antiaggregation therapy (DAT) from 12 to 48 months appears not to offer extra protection after...

solaci - 16 November, 2015

Coronary disease

DES and programmed surgery: reality or myth

Original title: Drug-Eluting Stents versus Bare Metal Stents Prior to Noncardiac Surgery. Reference: Sripal Bangalore, et al. Catheterization and Cardiovascular...

solaci - 12 May, 2015

Coronary disease

Randomized study of bioabsorbable polymer-coated sirolimus-eluting stent: DESSOLVE II protocol results

Original title: Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial. Reference: Wijns W EuroIntervention...

solaci - 8 May, 2015

Coronary disease

Everolimus eluting stent in total occlusions

Original title: Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization Results From the EXPERT...

solaci - 30 April, 2015

Coronary disease

Clinical presentation of restenosis in the three generations of DES

Original title: Clinical Presentation and Outcomes of Coronary In-Stent Restenosis Across 3-Stent Generations. Reference: Marco A. Magalhaes et al. Circ...

solaci - 28 April, 2015

Antithrombotic Anticoagulants

Duration of double antiaggregation therapy in patients with oral anticoagulation

Original title: Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent ImplantationThe ISAR-TRIPLE Trial. Reference: Katrin A....

solaci - 20 April, 2015

Chronic Ischemic cardiopathy

PCI with everolimus eluting stent or CABG for multivessel coronary artery disease.

Original title: Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Disease. Reference: Sripal Bangalore, M.D. et al. N Engl J...

solaci - 9 April, 2015

ABSORB III: Everolimus Eluting Bioresorbable Scaffolds for Coronary Artery Disease

OPTIDUAL: Dual Antiaggregation Not Beneficial after 12 Months.

DES and programmed surgery: reality or myth

Randomized study of bioabsorbable polymer-coated sirolimus-eluting stent: DESSOLVE II protocol results

Everolimus eluting stent in total occlusions

Clinical presentation of restenosis in the three generations of DES

Duration of double antiaggregation therapy in patients with oral anticoagulation

PCI with everolimus eluting stent or CABG for multivessel coronary artery disease.

Últimas Noticias

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

Noticias Institucionales

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Accesos